1. Point‐of‐Care test screening versus Case finding for paediatric coeliac disease: A pragmatic study in primary care.
- Author
-
Primavera, Giuseppe, Aiello, Andrea, Grosso, Caterina, Trifirò, Gianluca, Costa, Stefano, Grima, Anne‐Marie, Pallio, Socrate, Toumi, Mondher, Magazzu', Giuseppe, Pellegrino, Salvatore, Agnello, Vittoria, Cacioppo, Eleonora, Di Leonardo, Francesca, Ippolito, Giuseppe, Marciante, Giovanni, Montalbano, Ignazia, Montalbano, Vincenzo, Pennino, Domenica, Sanfilippo, Elisabetta, and Testoni, Maria
- Subjects
- *
POINT-of-care testing , *PRIMARY care , *IMMUNOGLOBULIN A - Abstract
In paediatric coeliac disease (CD), symptoms may not be a reliable factor in the diagnosis of coeliac disease as described by Rosen et al,1 and thus, recommendations for reviewing CD screening criteria were suggested.2 Apart from the costs, an important limiting factor in paediatric population mass screening using conventional immunoglobulin (Ig) A tissue transglutaminase (tTGIgA) may be the low compliance of asymptomatic children to be referred for testing. In the first one, a cost of + 20% for POCT was used, while in the second one, to compare POCT screening strategy vs CF, a cost for each FP visit of €15.44 was added to every patient in the CF. For this reason, we suggest that paediatricians utilise POCT in asymptomatic children only and refer children with clinical suspicion of CD for undergoing conventional serology; otherwise, testing for CD might be slowed down by a negative POCT. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF